The role of cyclic-AMP binding protein (CREB) in leukemia cell proliferation and acute leukemias.
Leukemia is a result of accumulating genetic alterations. The collaboration of mutations that offer survival and proliferative signals, together with mutations that result in lack of differentiation, is thought to cause a leukemic phenotype. The cyclic-AMP Response Element Binding Protein (CREB) is a transcription factor that is known to be a downstream component of the GM-CSF and IL-3 signaling pathways. We previously showed that CREB is overexpressed in blast cells from patients with acute leukemias. In this paper, we review the role of CREB in hematopoiesis, cell proliferation and acute leukemias.
Shankar
Deepa B
DB
Division of Hematology-Oncology, Gwynne-Hazen Cherry Memorial Laboratories, Mattel Children's Hospital, Los Angeles, CA 90095-1752, USA.
Sakamoto
Kathleen M
KM
D000818:Animals; D002455:Cell Division; D002470:Cell Survival; D017362:Cyclic AMP Response Element-Binding Protein / Q000378:metabolism*; D016207:Cytokines / Q000378:metabolism; D019143:Evolution, Molecular; D006410:Hematopoiesis; D006801:Humans; D007938:Leukemia / Q000378:metabolism*; D015470:Leukemia, Myeloid, Acute / Q000378:metabolism; D008954:Models, Biological; D009154:Mutation; D010641:Phenotype; D010766:Phosphorylation; D015398:Signal Transduction
D017362:Cyclic AMP Response Element-Binding Protein; D016207:Cytokines